ARTICLE | Company News
Peptech, Diversys research deal
April 5, 2001 7:00 AM UTC
Diversys ( Cambridge, U.K.) will develop single domain antibody drug candidates against four Peptech targets. Peptech (ASX:PTD) will pay Diversys a guaranteed $10 million in cash and invest $7 million...